Followers | 283 |
Posts | 1162 |
Boards Moderated | 0 |
Alias Born | 10/04/2020 |
Monday, February 15, 2021 1:06:17 AM
The primary and sole reason I decided to invest in ENZC revolves around a single element.."DISRUPTIVE BIOTECHNOLOGY" relative to the proven capacity to neutralize 95% of HIV isolates, combined with the recognition that the principals of this Company have a verifiable U.S. Patent on their Clone-3 mab, the same one Dr. Fauci attempted to lay claim to unsuccessfully. Fauci's career revolves around innovative research for treatment applications in various areas clinical medicine and he's among the most recognized M.D. research scientists of the 20th Century.
These factors combined, in and of itself, by far outweighed the negative stigmas associated with ENZC being on the OTC which I viewed as an anomaly, knowing full well that a Patent for any antibody derivative that can be utilized for drug development to treat AIDS/HIV is not only worth Billions, but has the capacity to fundamentally change the world they way we know it relative to the practice of clinical medicine for treating life threatening viral diseases. I knew I was looking at something that was undeniably revolutionary!
So yes, you're right, it was indeed a HUGE leap of Faith but one that made sense to me as a research physician and clinical trials professional.
They way I view the BIG PICTURE is they had to start somewhere so why not the OTC, for reason something like this that is life changing to the world couldn't remain in obscurity for long regardless of where it first appeared in public view.
Be well and prosper...
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
FEATURED DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM